Sunday - April 5, 2026
STEMI DTU Randomized Control Trial Demonstrates for the First Time that a Combination of Delayed Reperfusion and Left Ventricular Unloading Does Not Increase Myocardial Infarct Size
March 28, 2026
NEW BRUNSWICK, New Jersey, March 28 [Category: BizHealth & Beauty] -- Johnson and Johnson posted the following news release:

* * *

STEMI DTU Randomized Control Trial Demonstrates for the First Time that a Combination of Delayed Reperfusion and Left Ventricular Unloading Does Not Increase Myocardial Infarct Size

*

NEW ORLEANS - Johnson & Johnson (NYSE: JNJ) - March 28, 2026 - Randomized controlled trial (RCT) data presented at the Americ . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products